Insmed (INSM) Assets (2011 - 2026)
Insmed (INSM) posted Assets of $2.1 billion for Q2 2026, up 1.29% on a QoQ basis from $2.1 billion in Q1 2026, and down 15.21% year-over-year from $2.5 billion in Q2 2025.
Analysis
Insmed (INSM) Assets (2011 - 2026) Analysis & Trends
Insmed has reported Assets for 16 years, with the latest figure at $2.1 billion in Q2 2026.
- On a quarterly basis, Assets fell 15.21% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 15.21% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 11.82% from the prior year.
- Assets was $2.1 billion for Q2 2026 at Insmed, up from $2.1 billion in the prior quarter.
- The five-year high for Assets was $2.5 billion in Q2 2025, with the low at $994.8 million in Q3 2022.
- Average Assets over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
- The largest YoY upside for Assets was 66.57% in 2022 against a maximum downside of 24.16% in 2022.
- Over 5 years, Assets stood at $1.7 billion in 2022, then decreased by 19.72% to $1.3 billion in 2023, then soared by 52.29% to $2.0 billion in 2024, then grew by 11.82% to $2.3 billion in 2025, then fell by 7.15% to $2.1 billion in 2026.
- The last three Assets figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 2.10 Bn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | 23.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Bn |
| Mar 31, 2026 | 2.08 Bn |
| Dec 31, 2025 | 2.26 Bn |
| Sep 30, 2025 | 2.36 Bn |
| Jun 30, 2025 | 2.48 Bn |
| Mar 31, 2025 | 1.80 Bn |
| Dec 31, 2024 | 2.03 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.33 Bn |
| Sep 30, 2023 | 1.32 Bn |
| Jun 30, 2023 | 1.44 Bn |
| Mar 31, 2023 | 1.52 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 994.82 Mn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.15 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.31 Bn |